| PEAPOD NCT04804553 | Fase 3 | Reclutando pacientes |
| BEAN NCT04528082 | Fase 3 | Reclutando pacientes |
| A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis NCT05767047 | Fase 3 | Reclutando pacientes |
| Psoriasis en placas NCT06088199 | Fase 3 | Completado |
| Psoriasis en placas NCT05565560 | Fase 3 | Completado |
| Psoriasis NCT04175613 | Fase 3 | Completado |
| Psoriasis en placas NCT06122649 | Fase 3 | Completado |
| Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) NCT05174065 | Fase 3 | Completado |
| FOREMOST NCT03747939 | Fase 4 | Completado |
| Psoriasis NCT03701763 | Fase 3 | Completado |
| MOSAIC NCT03783026 | Fase 4 | Completado |
| PREVAIL NCT03828045 | no aplica | Completado |
| Psoriasis NCT03777436 | Fase 3 | Completado |
| COVID-19 NCT04590586 | Fase 3 | Completado |
| Psoriasis NCT03757013 | no aplica | Completado |
| APPRAISE NCT03608657 | no aplica | Completado |
| Psoriasis NCT03774875 | Fase 4 | Completado |
| Psoriasis en placas NCT04031027 | no aplica | Completado |
| A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis NCT04057937 | Fase 2 | Completado |
| Psoriasis en placas NCT03930186 | Fase 3 | Completado |
| Psoriasis NCT03721172 | Fase 3 | Completado |
| APOLO NCT03096990 | no aplica | Completado |
| Psoriasis NCT03097003 | no aplica | Completado |
| Psoriasis NCT03123471 | Fase 3 | Completado |
| A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease NCT02307513 | Fase 3 | Completado |
| Colitis ulcerosa NCT02289417 | Fase 2 | Completado |
| Psoriasis NCT02576678 | Fase 2 | Completado |
| Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects NCT02802735 | Fase 1 | Completado |
| Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension NCT02641353 | Fase 1 | Completado |
| UNVEIL NCT02425826 | Fase 4 | Completado |
| Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis NCT02087943 | Fase 2 | Completado |
| Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis NCT01925768 | Fase 3 | Completado |
| Psoriasis NCT01988103 | Fase 2 | Completado |
| Psoriasis NCT01690299 | Fase 3 | Completado |
| POSTURE NCT01583374 | Fase 3 | Completado |
| PALACE4 NCT01307423 | Fase 3 | Completado |
| PALACE 3 NCT01212770 | Fase 3 | Completado |
| PALACE2 NCT01212757 | Fase 3 | Completado |
| A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease NCT00866359 | Fase 2 | Completado |
| PALACE-1 NCT01172938 | Fase 3 | Completado |
| A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast NCT01561963 | Fase 1 | Completado |
| Psoriasis en placas NCT01232283 | Fase 3 | Completado |
| Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults NCT01634178 | Fase 1 | Completado |
| Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults NCT01634191 | Fase 1 | Completado |
| Psoriasis en placas NCT01194219 | Fase 3 | Completado |
| Artritis reumatoide NCT01285310 | Fase 2 | Interrumpido |
| Psoriasis NCT00773734 | Fase 2 | Completado |
| Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis NCT00456092 | Fase 2 | Completado |
| Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis NCT00521339 | Fase 2 | Completado |